The development trend analysis of glucagon-like peptide-1 receptor agonists from a patent perspective
Glucagon-like peptide-1 receptor agonists(GLP-1RA)have multiple physiological effects and significant economic value,which are of great significance for implementing innovation-driven development.GLP-1RA drugs are mostly monopolized by large foreign pharmaceutical companies,and there is an urgent need to break through technological barriers and achieve the localization process of related drugs.Based on the perspective of patent analysis,this article retrieved global patent data of GLP-1RA and analyzed it from perspectives of global overall situation of the patents,technology layout,and patent quality,including global application trends,regional distribution,key applicants,key enterprise patent layout,and core product patent layout.Statistical analysis showed that the number of GLP-1RA patents had been growing rapidly,with larger patent applications in the United States and Europe,the pharmaceutical companies actively made patent layout in major countries and regions worldwide,and the patent quality was high.China has a larger number of patents,but there is room for improvement in patent layout and patent quality.It is recommended to refer to foreign development experience,leverage our own advantages,and promote the global development and application of GLP-1RA technology in China.
NETL
NSTL
万方数据
